Royal Philips NV, a Dutch multinational corporation, revealed this week that it would be laying off thousands of employees worldwide. The company said it was forced to do so due to the plunging sales and other issues.
Philips said it would cut five percent of its workforce, and this is equivalent to about 4,000 people. The company's chief explained that this move is part of a scheme to combat the falling sales, which were partly due to the recall of its sleep apnea machine and eventually taking a massive hit from this - amounting to €1.3 billion.
The job cuts were revealed by Roy Jakobs, Philips' current chief executive officer, during the recent performance report for the third quarter of 2022. He confirmed that they had faced many challenges, and the Q3 report shows this.
Fox Business reported that the firm has 80,000 employees, and eliminating a small percentage is needed for the company to survive and for Philips to achieve its growth potential. It was noted that the firm incurred huge losses after recalling its Respironics Ventilators and other machines due to health risks.
These devices were sold around the world, and millions of units were already distributed, so the impact on the company was great. With this, Philips is expecting to see a mid to single-digit comparable sales decline in the last quarter of this year. As per Reuters, the job cuts may be worldwide but will mostly affect workers in the United States and the Netherlands.
"My immediate priority is to improve execution so that we can start rebuilding the trust of patients, consumers and customers, as well as shareholders and our other stakeholders," Royal Philips CEO, Roy Jakobs, said in a press release.
He further explained, "We will do this by first further strengthening our patient safety and quality management and addressing the various facets of the Philips Respironics recall by urgently improving our supply chain operations and simplifying our way of working to improve productivity and increase agility and this includes the difficult, but necessary decision to immediately reduce our workforce by around 4,000 roles globally."


Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
South Africa Eyes ECB Repo Lines as Inflation Eases and Rate Cuts Loom
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 



